Andrew D. Auerbach, MD, MPH; Russell S. Phillips, MD; Mary Beth Hamel, MD, MPH
Auerbach AD, Phillips RS, Hamel MB. Generalist and Cardiologist Care for Congestive Heart Failure. Ann Intern Med. 2000;133:482. doi: 10.7326/0003-4819-133-6-200009190-00022
Download citation file:
Published: Ann Intern Med. 2000;133(6):482.
Dr. Nurhussein points out differences between patients cared for by cardiologists and those cared for by generalists and wonders whether use of angiotensin-converting enzyme (ACE) inhibitors affects patient survival. Similar proportions of patients in each category received ACE inhibitors at the time of discharge. However, models adjusting for use of ACE inhibitors at discharge did not change short-term (30-day) or longer-term mortality findings. It remains possible that differences in dosing of ACE inhibitors may have affected patient survival, but our data do not permit us to discern these differences directly.
Our Table 1 displays in-hospital mortality, whereas our Table 5 displays mortality at 30 days of follow-up; differences in the percentages calculated by Dr. Nurhussein and those presented are due to censoring of data at time points after discharge.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only